Content Validation of Patient-Reported Sleep Measures and Development of a Conceptual Model of Sleep Disturbance in Patients with Moderate-to-Severe, Uncontrolled Asthma

References

• Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–1222.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Global strategy for asthma management and prevention; 2021. Available from: https://ginasthma.org/gina-reports/. Accessed February 22, 2023.
   Google Scholar
• Alanazi TM, Alghamdi HS, Alberreet MS, et al. The prevalence of sleep disturbance among asthmatic patients in a tertiary care center. Sci Rep. 2021;11(1):2457. doi:10.1038/s41598-020-79697-x
   PubMed Web of Science ®Google Scholar
• McDonald VM, Hiles SA, Jones KA, Clark VL, Yorke J. Health-related quality of life burden in severe asthma. Med J Aust. 2018;209(S2):S28–S33. doi:10.5694/mja18.00207
   PubMed Web of Science ®Google Scholar
• Mastronarde JG, Wise RA, Shade DM, Olopade CO, Scharf SM. American Lung Association Asthma Clinical Research C. Sleep quality in asthma: results of a large prospective clinical trial. J Asthma. 2008;45(3):183–189. doi:10.1080/02770900801890224
   PubMed Web of Science ®Google Scholar
• Luyster FS, Strollo PJ, Holguin F, et al. Association between insomnia and asthma burden in the Severe Asthma Research Program (SARP) III. Chest. 2016;150(6):1242–1250. doi:10.1016/j.chest.2016.09.020
   PubMed Web of Science ®Google Scholar
• Morphy H, Dunn KM, Lewis M, Boardman HF, Croft PR. Epidemiology of insomnia: a longitudinal study in a UK population. Sleep. 2007;30(3):274–280.
   PubMed Web of Science ®Google Scholar
• Fortier-Brochu E, Beaulieu-Bonneau S, Ivers H, Morin CM. Insomnia and daytime cognitive performance: a meta-analysis. Sleep Med Rev. 2012;16(1):83–94. doi:10.1016/j.smrv.2011.03.008
   PubMed Web of Science ®Google Scholar
• Lian Y, Xiao J, Liu Y, et al. Associations between insomnia, sleep duration and poor work ability. J Psychosom Res. 2015;78(1):45–51. doi:10.1016/j.jpsychores.2014.09.009
   PubMed Web of Science ®Google Scholar
• Burgoa V, Rejas J, Ojeda P, investigators of the Coste Asma study. Self-perceived sleep quality and quantity in adults with asthma: findings from the CosteAsma Study. J Investig Allergol Clin Immunol. 2016;26(4):256–262. doi:10.18176/jiaci.0044
   PubMed Web of Science ®Google Scholar
• Stone KL, Xiao Q. Impact of poor sleep on physical and mental health in older women. Sleep Med Clin. 2018;13(3):457–465. doi:10.1016/j.jsmc.2018.04.012
   PubMed Web of Science ®Google Scholar
• Scott D, Paterson JL, Happell B. Poor sleep quality in Australian adults with comorbid psychological distress and physical illness. Behav Sleep Med. 2014;12(4):331–341. doi:10.1080/15402002.2013.819469
   PubMed Web of Science ®Google Scholar
• Weldring T, Smith SM. Patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs). Health Serv Insights. 2013;6:61–68. doi:10.4137/HSI.S11093
   PubMedGoogle Scholar
• Juniper EF, O’Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902–907. doi:10.1034/j.1399-3003.1999.14d29.x
   PubMed Web of Science ®Google Scholar
• Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax. 1992;47(2):76–83. doi:10.1136/thx.47.2.76
   PubMed Web of Science ®Google Scholar
• Ding B, Small M, Bergstrom G, Holmgren U. A cross-sectional survey of night-time symptoms and impact of sleep disturbance on symptoms and health status in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:589–599. doi:10.2147/COPD.S122485
   PubMed Web of Science ®Google Scholar
• Chang CH, Chuang LP, Lin SW, et al. Factors responsible for poor sleep quality in patients with chronic obstructive pulmonary disease. BMC Pulm Med. 2016;16(1):118. doi:10.1186/s12890-016-0281-6
   PubMedGoogle Scholar
• Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540–545. doi:10.1093/sleep/14.6.540
   PubMed Web of Science ®Google Scholar
• Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO instrument. Value Health. 2011;14(8):967–977. doi:10.1016/j.jval.2011.06.014
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. Patient-reported outcome measures: use in medical product development to support labeling claims; 2020. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf. Accessed February 22, 2023.
   Google Scholar
• Food and Drug Administration. Patient-focused drug development guidance: methods to identify what is important to patients and select, develop or modify fit-for-purpose clinical outcome assessments; 2020. Available from: https://www.fda.gov/drugs/news-events-human-drugs/patient-focused-drug-development-guidance-methods-identify-what-important-patients-and-select. Accessed February 22, 2023.
   Google Scholar
• Juniper EF, Bousquet J, Abetz L, Bateman ED, Committee G. Identifying ‘well-controlled’ and ‘not well-controlled’ asthma using the Asthma Control Questionnaire. Respir Med. 2006;100(4):616–621. doi:10.1016/j.rmed.2005.08.012
   PubMed Web of Science ®Google Scholar
• Department of Health and Human Services. 45 CFR 46.117 Documentation of Informed Consent; 2022. Available from: https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-A/part-46/subpart-A/section-46.117. Accessed February 22, 2023.
   Google Scholar
• Food and Drug Administration. FDA guidance on conduct of clinical trials of medical products during COVID-19 pandemic: guidance for industry, investigators, and institutional review boards; 2020. Available from: https://www.fda.gov/media/136238/download. Accessed February 22, 2023.
   Google Scholar
• Food and Drug Administration. Patient-focused drug development: methods to identify what is important to patients. Guidance for industry, Food and Drug Administration staff, and other stakeholders; 2022. Available from: https://www.fda.gov/media/131230/download. Accessed February 22, 2023.
   Google Scholar
• Rothman M, Burke L, Erickson P, Leidy NK, Patrick DL, Petrie CD. Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report. Value Health. 2009;12(8):1075–1083. doi:10.1111/j.1524-4733.2009.00603.x
   PubMed Web of Science ®Google Scholar
• Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding. Value Health. 2011;14(8):978–988. doi:10.1016/j.jval.2011.06.013
   PubMed Web of Science ®Google Scholar
• Busse WW, Maspero JF, Rabe KF, et al. Liberty Asthma QUEST: phase 3 randomized, double-blind, placebo-controlled, parallel-group study to evaluate dupilumab efficacy/safety in patients with uncontrolled, moderate-to-severe asthma. Adv Ther. 2018;35(5):737–748. doi:10.1007/s12325-018-0702-4
   PubMed Web of Science ®Google Scholar
• Corren J, Castro M, Chanez P, et al. Dupilumab improves symptoms, quality of life, and productivity in uncontrolled persistent asthma. Ann Allergy Asthma Immunol. 2019;122(1):41–49 e42. doi:10.1016/j.anai.2018.08.005
   PubMed Web of Science ®Google Scholar
• Kelsay K. Management of sleep disturbance associated with atopic dermatitis. J Allergy Clin Immunol. 2006;118(1):198–201. doi:10.1016/j.jaci.2006.04.038
   PubMed Web of Science ®Google Scholar
• Hanish AE, Lin-Dyken DC, Han JC. PROMIS sleep disturbance and sleep-related impairment in adolescents: examining psychometrics using self-report and actigraphy. Nurs Res. 2017;66(3):246–251. doi:10.1097/NNR.0000000000000217
   PubMed Web of Science ®Google Scholar
• Yu L, Buysse DJ, Germain A, et al. Development of short forms from the PROMIS sleep disturbance and Sleep-Related Impairment item banks. Behav Sleep Med. 2011;10(1):6–24. doi:10.1080/15402002.2012.636266
   PubMed Web of Science ®Google Scholar
• Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101. doi:10.1191/1478088706qp063oa
   Google Scholar
• Castro M, Corren J, Pavord ID, et al. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med. 2018;378(26):2486–2496. doi:10.1056/NEJMoa1804092
   PubMed Web of Science ®Google Scholar
• Lei DK, Yousaf M, Janmohamed SR, et al. Validation of patient-reported outcomes information system sleep disturbance and sleep-related impairment in adults with atopic dermatitis. Br J Dermatol. 2020;183(5):875–882. doi:10.1111/bjd.18920
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov. Dupilumab asthma sleep study (MORPHEO). ClinicalTrials.gov Identifier: NCT04502862; 2021. Available from: https://clinicaltrials.gov/ct2/show/NCT04502862. Accessed February 22, 2023.
   Google Scholar
• Sprangers MAG, Schwartz CE. Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med. 1999;48(11):1507–1515. doi:10.1016/S0277-9536(99)00045-3
   PubMed Web of Science ®Google Scholar
• Schwartz CE, Andresen EM, Nosek MA, Krahn GL, Measurement R. Response shift theory: important implications for measuring quality of life in people with disability. Arch Phys Med Rehabil. 2007;88(4):529–536. doi:10.1016/j.apmr.2006.12.032
   PubMed Web of Science ®Google Scholar